290 related articles for article (PubMed ID: 21293193)
1. Candidate pathways linking inducible nitric oxide synthase to a basal-like transcription pattern and tumor progression in human breast cancer.
Ambs S; Glynn SA
Cell Cycle; 2011 Feb; 10(4):619-24. PubMed ID: 21293193
[TBL] [Abstract][Full Text] [Related]
2. Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.
Switzer CH; Cheng RY; Ridnour LA; Glynn SA; Ambs S; Wink DA
Breast Cancer Res; 2012 Sep; 14(5):R125. PubMed ID: 22971289
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.
Heinecke JL; Ridnour LA; Cheng RY; Switzer CH; Lizardo MM; Khanna C; Glynn SA; Hussain SP; Young HA; Ambs S; Wink DA
Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6323-8. PubMed ID: 24733928
[TBL] [Abstract][Full Text] [Related]
4. S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer.
Switzer CH; Glynn SA; Cheng RY; Ridnour LA; Green JE; Ambs S; Wink DA
Mol Cancer Res; 2012 Sep; 10(9):1203-15. PubMed ID: 22878588
[TBL] [Abstract][Full Text] [Related]
5. Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.
Glynn SA; Boersma BJ; Dorsey TH; Yi M; Yfantis HG; Ridnour LA; Martin DN; Switzer CH; Hudson RS; Wink DA; Lee DH; Stephens RM; Ambs S
J Clin Invest; 2010 Nov; 120(11):3843-54. PubMed ID: 20978357
[TBL] [Abstract][Full Text] [Related]
6. Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.
Basudhar D; Somasundaram V; de Oliveira GA; Kesarwala A; Heinecke JL; Cheng RY; Glynn SA; Ambs S; Wink DA; Ridnour LA
Antioxid Redox Signal; 2017 Jun; 26(18):1044-1058. PubMed ID: 27464521
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer.
Basudhar D; Glynn SA; Greer M; Somasundaram V; No JH; Scheiblin DA; Garrido P; Heinz WF; Ryan AE; Weiss JM; Cheng RYS; Ridnour LA; Lockett SJ; McVicar DW; Ambs S; Wink DA
Proc Natl Acad Sci U S A; 2017 Dec; 114(49):13030-13035. PubMed ID: 29087320
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation.
Ridnour LA; Barasch KM; Windhausen AN; Dorsey TH; Lizardo MM; Yfantis HG; Lee DH; Switzer CH; Cheng RY; Heinecke JL; Brueggemann E; Hines HB; Khanna C; Glynn SA; Ambs S; Wink DA
PLoS One; 2012; 7(9):e44081. PubMed ID: 22957045
[TBL] [Abstract][Full Text] [Related]
9. NOS2 as an Emergent Player in Progression of Cancer.
Thomas DD; Wink DA
Antioxid Redox Signal; 2017 Jun; 26(17):963-965. PubMed ID: 28506076
[TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer.
Wang J; He P; Gaida M; Yang S; Schetter AJ; Gaedcke J; Ghadimi BM; Ried T; Yfantis H; Lee D; Weiss JM; Stauffer J; Hanna N; Alexander HR; Hussain SP
Oncotarget; 2016 Aug; 7(33):52993-53004. PubMed ID: 27367029
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of the inducible nitric oxide synthase (NOS2) splicing variant S3 promotes autophagic cell death from nitrosative stress in SW480 human colon cancer cells.
Castro ED; Mathias PPM; Batista WL; Sato AYS; Toledo MS; de Almeida VT; Curcio MF; da Costa PE; Stern A; Monteiro HP
Cell Biol Int; 2022 Jan; 46(1):158-169. PubMed ID: 34719858
[TBL] [Abstract][Full Text] [Related]
12. Reduced nitric oxide synthase 2 (NOS2) promoter activity in the Syrian hamster renders the animal functionally deficient in NOS2 activity and unable to control an intracellular pathogen.
Perez LE; Chandrasekar B; Saldarriaga OA; Zhao W; Arteaga LT; Travi BL; Melby PC
J Immunol; 2006 May; 176(9):5519-28. PubMed ID: 16622021
[TBL] [Abstract][Full Text] [Related]
13. NRF2 interacts with distal enhancer and inhibits nitric oxide synthase 2 expression in KRAS-driven pancreatic cancer cells.
Di Giorgio E; Cortolezzis Y; Gualandi N; Agostini F; Rapozzi V; Xodo LE
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119606. PubMed ID: 37852325
[TBL] [Abstract][Full Text] [Related]
14. Inducible nitric oxide synthase-derived extracellular nitric oxide flux regulates proinflammatory responses at the single cell level.
Somasundaram V; Gilmore AC; Basudhar D; Palmieri EM; Scheiblin DA; Heinz WF; Cheng RYS; Ridnour LA; Altan-Bonnet G; Lockett SJ; McVicar DW; Wink DA
Redox Biol; 2020 Jan; 28():101354. PubMed ID: 31683257
[TBL] [Abstract][Full Text] [Related]
15. The Chemical Biology of NO that Regulates Oncogenic Signaling and Metabolism: NOS2 and Its Role in Inflammatory Disease.
Miranda KM; Ridnour LA; Cheng RYS; Wink DA; Thomas DD
Crit Rev Oncog; 2023; 28(1):27-45. PubMed ID: 37824385
[TBL] [Abstract][Full Text] [Related]
16. Binding of CAP70 to inducible nitric oxide synthase and implications for the vectorial release of nitric oxide in polarized cells.
Navarro-Lérida I; Martínez-Moreno M; Ventoso I; Alvarez-Barrientos A; Rodríguez-Crespo I
Mol Biol Cell; 2007 Jul; 18(7):2768-77. PubMed ID: 17507652
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte survival in acute hepatitis is due to c-Jun/AP-1-dependent expression of inducible nitric oxide synthase.
Hasselblatt P; Rath M; Komnenovic V; Zatloukal K; Wagner EF
Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17105-10. PubMed ID: 17940019
[TBL] [Abstract][Full Text] [Related]
18. High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.
Puglisi MA; Cenciarelli C; Tesori V; Cappellari M; Martini M; Di Francesco AM; Giorda E; Carsetti R; Ricci-Vitiani L; Gasbarrini A
J Pathol; 2015 Aug; 236(4):479-90. PubMed ID: 25875314
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and IGF-I activate the Akt pathway in breast cancer.
Prueitt RL; Boersma BJ; Howe TM; Goodman JE; Thomas DD; Ying L; Pfiester CM; Yfantis HG; Cottrell JR; Lee DH; Remaley AT; Hofseth LJ; Wink DA; Ambs S
Int J Cancer; 2007 Feb; 120(4):796-805. PubMed ID: 17096325
[TBL] [Abstract][Full Text] [Related]
20. IL-17 intensifies IFN-γ-induced NOS2 upregulation in RAW 264.7 cells by further activating STAT1 and NF-κB.
Gao Q; Liu Y; Wu Y; Zhao Q; Wang L; Gao S; Wen W; Zhang W; Guo N; Zhou J; Yuan Z
Int J Mol Med; 2016 Feb; 37(2):347-58. PubMed ID: 26677135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
